LCN2 and systemic lupus erythematosus: Exposure of kidney mesangial cells to these pathogenic autoantibodies strongly upregulated lipocalin-2 expression [106], which raised the possibility that urinary lipocalin-2 levels could serve as a biomarker to discriminate between SLE patients with or without lupus nephritis.